Dwayne C. Jones

Array ( [id] => 1193166 [patent_doc_number] => 06730665 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Treatment of bone cancer' [patent_app_type] => B1 [patent_app_number] => 10/018287 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5844 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730665.pdf [firstpage_image] =>[orig_patent_app_number] => 10018287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786470 [patent_doc_number] => 20020160056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Method and devices for transdermal delivery of lithium' [patent_app_type] => new [patent_app_number] => 10/127257 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7306 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160056.pdf [firstpage_image] =>[orig_patent_app_number] => 10127257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5788737 [patent_doc_number] => 20020161020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Stablization of quinapril using magnesium oxide' [patent_app_type] => new [patent_app_number] => 10/127181 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4983 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161020.pdf [firstpage_image] =>[orig_patent_app_number] => 10127181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783568 [patent_doc_number] => 20030065016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Nordihydroguaiartic derivatives for use in treatment of tumors' [patent_app_type] => new [patent_app_number] => 10/119899 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12494 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20030065016.pdf [firstpage_image] =>[orig_patent_app_number] => 10119899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053312 [patent_doc_number] => 06858641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Substituted indolinones' [patent_app_type] => utility [patent_app_number] => 10/116365 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13743 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858641.pdf [firstpage_image] =>[orig_patent_app_number] => 10116365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474847 [patent_doc_number] => 20040097540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/473809 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9128 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097540.pdf [firstpage_image] =>[orig_patent_app_number] => 10473809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766139 [patent_doc_number] => 20030100539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Methods of treating neurological disorders with group I mGluR antagonists' [patent_app_type] => new [patent_app_number] => 10/114433 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25793 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100539.pdf [firstpage_image] =>[orig_patent_app_number] => 10114433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692308 [patent_doc_number] => 20030039740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Composition for enteral nutrition comprising fibres' [patent_app_type] => new [patent_app_number] => 10/113470 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3137 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039740.pdf [firstpage_image] =>[orig_patent_app_number] => 10113470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568974 [patent_doc_number] => 20020165240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Method of treating proliferative diseases using Eg5 inhibitors' [patent_app_type] => new [patent_app_number] => 10/108403 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13828 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165240.pdf [firstpage_image] =>[orig_patent_app_number] => 10108403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6788157 [patent_doc_number] => 20030139396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'METHOD OF TREATMENT' [patent_app_type] => new [patent_app_number] => 10/108659 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1426 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20030139396.pdf [firstpage_image] =>[orig_patent_app_number] => 10108659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625419 [patent_doc_number] => 06723750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Photodynamic therapy for pre-melanomas' [patent_app_type] => B2 [patent_app_number] => 10/099239 [patent_app_country] => US [patent_app_date] => 2002-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9491 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723750.pdf [firstpage_image] =>[orig_patent_app_number] => 10099239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261715 [patent_doc_number] => 20020187920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Dopamine D4 receptor antagonists as treatment for attention deficit-hyperactivity disorder' [patent_app_type] => new [patent_app_number] => 10/096673 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3514 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187920.pdf [firstpage_image] =>[orig_patent_app_number] => 10096673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1282105 [patent_doc_number] => 06642265 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Thrombopoietin mimetics' [patent_app_type] => B1 [patent_app_number] => 10/070702 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8136 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 362 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642265.pdf [firstpage_image] =>[orig_patent_app_number] => 10070702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765327 [patent_doc_number] => 20030099726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => ' Antimicrobial treatment for herpes simplex virus and other infectious diseases' [patent_app_type] => new [patent_app_number] => 10/093093 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9326 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099726.pdf [firstpage_image] =>[orig_patent_app_number] => 10093093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228898 [patent_doc_number] => 06696495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-24 [patent_title] => 'Treatment of disorders secondary to organic impairments' [patent_app_type] => B2 [patent_app_number] => 10/092144 [patent_app_country] => US [patent_app_date] => 2002-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13029 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696495.pdf [firstpage_image] =>[orig_patent_app_number] => 10092144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751008 [patent_doc_number] => 20030045529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Method for specifically potentiating N-type Ca2+ channel activity' [patent_app_type] => new [patent_app_number] => 10/084160 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4421 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045529.pdf [firstpage_image] =>[orig_patent_app_number] => 10084160 [rel_patent_id] =>[rel_patent_doc_number] =>)